Co-administration of additional drugs that protect PI3K/Akt/GSK-3β signaling [such as thymoquinone (93) and cyclosporine A (94)] reversed the inhibitory effect of chronic hyperglycemia on IPostC and provided additional cardioprotection in diabetic rats’ hearts. This evidence concerns the gene AKT1 and Hyperglycemia.